Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026)

Elanco Animal Health has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $366.0 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 23.91% year-over-year to $366.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $366.0 million (down 23.91% YoY) and the FY2025 annual result came in at $382.0 million, down 14.92% from the prior year.
• Non-Current Deferred Tax Liability retreated to $366.0 million in Q1 2026 per ELAN's latest filing, from $382.0 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $1.1 billion in Q4 2022 and troughed at $366.0 million in Q1 2026.
• A 5-year average of $578.4 million and a median of $539.0 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability soared 40.13% in 2022, then sank 47.11% in 2023.
• Over 5 years, Non-Current Deferred Tax Liability stood at $1.1 billion in 2022, then slumped by 47.11% to $567.0 million in 2023, then declined by 20.81% to $449.0 million in 2024, then dropped by 14.92% to $382.0 million in 2025, then slipped by 4.19% to $366.0 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $366.0 million, $382.0 million, and $478.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.